From DNA To Decision

Fast functional testing of genetic variants, from newborn genomes to disease models like zebrafish, is transforming ambiguous DNA findings into confident, real‑time treatment decisions.

An ASU frat leader 'frame-mogged' a major livestreamer — and the internet erupted

In certain corners of the internet — and inside middle school classrooms — the worst thing that can happen to you in 2026 isn ...
strategy+business

Power moves

Energy economics expert Michael Pollitt explains why the most muscular solutions to the world’s energy transition are global.
All Penny Stocks (English) on MSN

Femtech Microcap Enters U.S. Market With AI-Powered Wellness Device, Shares Climb

The femtech sector, comprised of products, software, devices, and services specifically designed to address women’s health and wellness needs, continues to gain momentum as technology reshapes how ...

Dr. Julian A. Reed’s Groundbreaking Research Links Upper Body Strength to Academic Success in Youth

Findings Reinforce ActivEd's Mission to Transform Learning Through Movement GREENVILLE, SC, UNITED STATES, February 10, ...

Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook

We were honored to receive the 2025 Clinical Trials Arena R&D Excellence Award in the Precision Endocrine Therapy category, reflecting growing awareness of the utility of (Z)-endoxifen across oncology ...
Interesting Engineering on MSN

How Russia’s nuclear forces shape Norway’s Arctic defense strategy

Norway is further strengthening its military forces to prepare for a potential Russian land ...
Medscape

FDA Updates Axi-Cel Safety Label for Large B-Cell Lymphoma

The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...

Banijay Entertainment to Hit London TV Screenings With ‘A Woman of Substance’ and ‘Falling,’ Plus an Expansive Format Slate Led by ‘Football Island’ (EXCLUSIVE)

Banijay Entertainment is set to unveil one of the biggest and broadest of lineups at the 2026 London TV Screenings, led by a ...

FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the ...
The Daily Galaxy on MSN

Scientists prove physical exercise rewires the brain to solve the fatigue paradox

Unlike the clear physical markers of muscular fatigue, the weary mind lacks a visible byproduct like lactic acid. This ...